Instrument Inactif

Communiqués CanniMed Therapeutics Inc

Actions

CMED

CA13767U1093

Produits pharmaceutiques

Communiqués

16/03/18	CanniMed Therapeutics Inc. : Announces Quarterly Results Release Date	BU
09/03/18	CanniMed Therapeutics : Aurora Cannabis Announces Success in Bid for CanniMed Therapeutics Through the Take-Up of Shares	BU
24/01/18	IIROC Trade Resumption - CanniMed Therapeutics Inc.	NE
24/01/18	IIROC Trade Halt - CanniMed Therapeutics Inc.	NE
23/01/18	CanniMed Therapeutics : Announces Continued Discussions with Aurora	BU
18/01/18	IIROC Trade Resumption - CanniMed Therapeutics Inc.	NE
18/01/18	IIROC Trade Halt - CanniMed Therapeutics Inc.	NE
03/01/18	CanniMed Therapeutics : Releases New Letter to Shareholders	BU
20/11/17	IIROC Trade Resumption - CanniMed Therapeutics Inc.	NE
20/11/17	CanniMed Therapeutics Inc. : Announces Director Resignation	BU
18/11/17	CanniMed to Acquire Up Cannabis Inc. (Newstrike Resources Ltd. - TSX-V: HIP) to Create a Premier Global Cannabis Company	MW
17/11/17	IIROC Trade Halt - CanniMed Therapeutics Inc.	NE
15/11/17	IIROC Trade Resumption - CanniMed Therapeutics Inc.	NE
15/11/17	IIROC Trade Halt - CanniMed Therapeutics Inc.	NE
14/09/17	CanniMed Therapeutics : Adds to Executive Leadership Team	PU
05/09/17	CanniMed Therapeutics Inc. : Announces 2017 Third Quarter Results Release Date	BU
24/08/17	CanniMed Therapeutics : Expands International Supply Partnerships to Africa	PU
12/06/17	CanniMed Therapeutics Inc. : Reports Financial Results for Q2 2017	BU
05/06/17	CanniMed Therapeutics : Announces 2017 Second Quarter Results Release Date	PU
17/02/17	CanniMed Therapeutics : CTT Pharmaceutical Holdings and CanniMed Therapeutics Inc. Complete Exclusive Canadian Licensing Agreement for Cannabis Orally Dissolvable Thin Film (ODF) Wafer	BU